Glen Tullman is the CEO of Transcarent, a consumer-directed health platform that simplifies access to high-quality, affordable care. Transcarent uses WayFinding, powered by clinicians and AI, to provide trusted health navigation, personalized clinical guidance, and on-demand care. Tullman founded Livongo Health, empowering people with chronic conditions through data science. He led Livongo’s IPO, raising over $550 million, and its merger with Teladoc Health, valuing Livongo at $18.5 billion. Tullman also led Allscripts and Enterprise Systems, taking both public. He’s a founding partner at 7wireVentures and a philanthropist, honored with the Robert F. Kennedy Human Rights Ripple of Hope Award.